GlassScriptPhysician profile
Pritesh Mukesh Patel
NPI 1356695688
$23,788.68
in general payments reported to CMS, 2019-2025
30 companies · $1,044 in 2025
The $1,044 reported for 2025 was more than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,613 · 2020: $1,544 · 2021: $5,826 · 2022: $8,508 · 2023: $3,089 · 2024: $1,166 · 2025: $1,044.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,105 · Travel and Lodging: $1,141 · Education: $52.44.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,104.78 |
| Travel and Lodging | $1,141.17 |
| Education | $52.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spinal Simplicity, LLC | $9,955.36 | 2021-2023 | Ha Minuteman G3-R |
| Medtronic USA, INC. | $2,879.88 | 2019-2020 | |
| Nevro Corp. | $2,778.03 | 2019-2023 | Senza |
| Abbott Laboratories | $2,333.52 | 2019-2025 | Proclaim, Eterna |
| Medtronic, INC. | $2,153.10 | 2021-2024 | Synchromedii, Intellis Adaptivestim, Vanta Adaptivestim |
| Curonix LLC | $874.05 | 2022-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Stimwave Technologies Incorporated | $426.56 | 2021-2022 | |
| Boston Scientific Corporation | $287.05 | 2019-2022 | |
| Biohaven Pharmaceuticals, INC. | $267.80 | 2021 | |
| Nalu Medical, INC. | $211.02 | 2023 | Nalu Neurostimulation System |
| Horizon Therapeutics Plc | $206.42 | 2020-2022 | |
| Vgi Medical, LLC | $189.01 | 2022 | |
| Collegium Pharmaceutical, INC. | $185.60 | 2020-2021 | |
| Biodelivery Sciences International, INC. | $148.28 | 2020-2021 | |
| Vertex Pharmaceuticals Incorporated | $124.99 | 2025 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $107.47 | 2023-2024 | |
| Grt US Holding, INC. | $103.80 | 2022 | |
| Pfizer INC. | $89.03 | 2019-2023 | |
| Pacira Therapeutics, INC. | $75.37 | 2019-2020 | |
| Zimmer Biomet Holdings, INC. | $73.52 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $55.75 | 2022 | |
| Scilex Pharmaceuticals INC. | $46.26 | 2019 | |
| Arbor Pharmaceuticals, INC. | $38.51 | 2021 | |
| Relievant Medsystems, INC. | $35.72 | 2023 | Intracept |
| Astrazeneca Pharmaceuticals LP | $31.76 | 2024 | Flumist Quadrivalent |
| Abbvie INC. | $26.91 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $26.16 | 2019-2020 | |
| Fidia Pharma USA INC. | $22.00 | 2022 | |
| Valinor Pharma, LLC | $19.49 | 2023 | Movantik |
| Spr Therapeutics, INC | $16.26 | 2023 | Sprint Pns System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pritesh Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.